Security
Accendra Health, Inc. · ACH
ACHNYSECommon stockCurrentCIK 75252Updated Oct 12, 2026
Name history
OWENS & MINOR INC/VA/ · through Dec 31, 2025O&M HOLDING INC · through Jun 17, 1994OWENS & MINOR INC · through Mar 9, 1994
ACH price & chart
Loading TradingView…
NYSE:ACH on TradingView ↗About the company
Accendra Health, Inc. (NYSE: ACH) is a leading nationwide provider of products, technology, and services that support health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex health conditions. Backed by the industry-leading expertise of our Apria and Byram brands, Accendra Health is reimagining the future of home-based care. To learn more about our broad portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology, and ostomy, visit www.accendrahealth.com.
In the news
The Alchemy Chain Mainnet is Live ↗
Recent filings
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD Disclosure
Items 3.01, 7.01, 9.01
SCHEDULE 13G - filed by BANK OF AMERICA CORP /DE/ regarding ACCENDRA HEALTH INC/VA/
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure · Other Events
Items 5.02, 7.01, 8.01, 9.01
144 filing
Show 5 more recent filings
Regulation FD Disclosure
Items 7.01, 9.01
8-A12B filing
Entry into a Material Definitive Agreement · Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure
Items 1.01, 3.03, 5.03, 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 2,451,761,000Source | 4,656,156,000Source | 5,093,322,000Source | 5,386,283,000Source |
| Property, Plant and Equipment, NetUSD | 256,161,000Source | 249,283,000Source | — | — |
| GoodwillUSD | 1,228,140,000Source | 1,331,281,000Source | 1,638,846,000Source | 1,636,705,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 136,465,000Source | 298,726,000Source | 361,835,000Source | 445,042,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 281,989,000Source | 49,382,000Source | 243,037,000Source | 69,467,000Source |
| Inventory, NetUSD | 74,435,000Source | 1,131,879,000Source | 1,110,606,000Source | 1,333,585,000Source |
| Assets, CurrentUSD | 547,871,000Source | 2,021,017,000Source | 2,102,790,000Source | 2,295,185,000Source |
| Operating Lease, Right-of-Use AssetUSD | 109,099,000Source | 355,627,000Source | 296,533,000Source | 280,665,000Source |
| Other Assets, NoncurrentUSD | 174,025,000Source | 140,158,000Source | 149,346,000Source | 150,417,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,912,739,000Source | 4,090,930,000Source | 4,169,156,000Source | 4,440,679,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 152,777,000Source | 154,398,000Source | 153,092,000Source | 152,557,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,079,752,000Source | 6,021,000Source | 368,707,000Source | 410,008,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -885,000Source | -49,344,000Source | -31,818,000Source | -35,855,000Source |
| Stockholders' Equity Attributable to ParentUSD | -460,978,000Source | 565,226,000Source | 924,166,000Source | 945,604,000Source |
| Additional Paid in Capital, Common StockUSD | 466,882,000Source | 454,151,000Source | 434,185,000Source | 418,894,000Source |
| Liabilities and EquityUSD | 2,451,761,000Source | 4,656,156,000Source | 5,093,322,000Source | 5,386,283,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 947,075,000Source | 1,873,739,000Source | 1,891,885,000Source | 1,566,466,000Source |
| Operating Lease, Liability, CurrentUSD | 43,272,000Source | 91,221,000Source | 85,665,000Source | 76,805,000Source |
| Accounts Payable, CurrentUSD | 363,565,000Source | 1,251,964,000Source | 1,171,882,000Source | 1,147,414,000Source |
| Operating Lease, Liability, NoncurrentUSD | 70,317,000Source | 286,212,000Source | 222,429,000Source | 215,469,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | 22,456,000Source | 41,652,000Source | 60,833,000Source |
| Other Liabilities, NoncurrentUSD | 95,471,000Source | 100,476,000Source | 122,592,000Source | 114,943,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | — | 1,316,000Source | 26,679,000Source | 51,184,000Source |
| Long-term Debt, Current MaturitiesUSD | 250,000,000Source | 45,549,000Source | 206,904,000Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -1,100,642,000Source | — | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 214,524,000Source | 264,775,000Source | 287,377,000Source | 228,667,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 12,873,000Source | 26,836,000Source | 23,218,000Source | 20,993,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 6,854,000Source | 26,228,000Source | -224,338,000Source | -166,559,000Source |
| Deferred Income Tax Expense (Benefit)USD | -17,887,000Source | -26,115,000Source | -23,733,000Source | -26,361,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | 161,495,000Source | 740,710,000Source | 325,006,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 18,091,000Source | — | 0Source | 1,684,607,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 144,423,000Source | -116,533,000Source | -137,254,000Source | -1,804,476,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 1,910,000Source | -8,203,000Source | 936,000Source | 1,670,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 190,956,000Source | 210,865,000Source | 190,870,000Source | 158,090,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 10,179,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 188,078,000Source | -267,603,000Source | -417,330,000Source | 1,497,105,000Source |
| Dividends paid | — | — | — | — |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -3,116,000Source | -23,406,000Source | -637,000Source | -42,793,000Source |
| Repayments of Long-term DebtUSD | — | 244,197,000Source | 320,693,000Source | 4,500,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 232,607,000Source | -223,542,000Source | 186,739,000Source | 14,150,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 49,382,000Source | 272,924,000Source | 86,185,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 134,710,000Source | 141,547,000Source | 153,247,000Source | 107,022,000Source |
| Income Taxes Paid, NetUSD | 12,471,000Source | 5,553,000Source | -6,283,000Source | 33,973,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,896,000Source | -901,000Source | 613,000Source | -3,485,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 23,218,000Source | — |
| Amortization of Intangible AssetsUSD | 74,000,000Source | 64,943,000Source | 83,500,000Source | 78,800,000Source |
| Capitalized Computer Software, AmortizationUSD | — | 17,000,000Source | 16,100,000Source | 14,000,000Source |
| DepreciationUSD | — | 183,000,000Source | 188,000,000Source | 136,000,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | 7,400,000Source | — | — |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | 0Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 27,274,000Source | 44,705,000Source | 34,882,000Source | 26,260,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | -1,101,000Source | 3,518,000Source | 0Source |
| GoodwillUSD | 1,228,140,000Source | 1,331,281,000Source | 1,638,846,000Source | 1,636,705,000Source |
| Goodwill, Impairment LossUSD | 0Source | 307,112,000Source | 0Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -102,682,000Source | — | — | 22,389,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -102,682,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -997,960,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -997,960,000Source | — | — | 0Source |
| Income Tax Expense (Benefit)USD | 729,000Source | 5,329,000Source | -13,425,000Source | -11,498,000Source |
| InterestExpenseNonoperatingUSD | 107,183,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -1,100,642,000Source | -362,686,000Source | -41,301,000Source | 22,389,000Source |
| Nonoperating Income (Expense)USD | -3,942,000Source | -4,683,000Source | -4,837,000Source | -3,131,000Source |
| Operating Costs and ExpensesUSD | 2,734,572,000Source | — | — | — |
| Other Depreciation and AmortizationUSD | — | 12,965,000Source | — | — |
| Other Operating Income (Expense), NetUSD | — | -13,316,000Source | -6,930,000Source | 5,252,000Source |
| Payments of Financing CostsUSD | — | 0Source | 0Source | 42,602,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 2,762,032,000Source | 10,700,883,000Source | 10,333,967,000Source | 9,955,475,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 1,067,560,000Source | 1,909,791,000Source | 1,813,559,000Source | 1,633,668,000Source |
| Operating Income (Loss)USD | 27,460,000Source | -207,769,000Source | 104,508,000Source | 142,913,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -101,953,000Source | -357,357,000Source | -54,726,000Source | 10,891,000Source |
| Income Tax Expense (Benefit)USD | 729,000Source | 5,329,000Source | -13,425,000Source | -11,498,000Source |
| Net Income (Loss) Attributable to ParentUSD | -1,100,642,000Source | -362,686,000Source | -41,301,000Source | 22,389,000Source |
| Earnings Per Share, BasicUSD per share | -14.31Source | -4.73Source | -0.54Source | 0.3Source |
| Earnings Per Share, DilutedUSD per share | -14.31Source | -4.73Source | -0.54Source | 0.29Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 76,897,000Source | 76,741,000Source | 75,785,000Source | 74,496,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 76,897,000Source | 76,741,000Source | 75,785,000Source | 76,217,000Source |
| Interest Expense (non-operating)USD | 107,183,000Source | — | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 74,000,000Source | 64,943,000Source | 83,500,000Source | 78,800,000Source |
| Business Combination, Acquisition Related CostsUSD | 22,000,000Source | 22,000,000Source | 17,500,000Source | — |
| Capitalized Computer Software, AmortizationUSD | — | 17,000,000Source | 16,100,000Source | 14,000,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | 1,323,336,000Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | 18,616,000Source | 31,444,000Source | 10,308,000Source | 14,863,000Source |
| Goodwill, Impairment LossUSD | 0Source | 307,112,000Source | 0Source | — |
| Gross ProfitUSD | — | 2,219,155,000Source | 2,125,161,000Source | 1,826,351,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -102,682,000Source | — | — | 22,389,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -104,080,000Source | -383,475,000Source | -65,432,000Source | -17,650,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -102,682,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -1.34Source | -4.73Source | -0.54Source | 0.3Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | -1.34Source | -4.73Source | -0.54Source | 0.29Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -997,960,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -997,960,000Source | — | — | 0Source |
| Interest ExpenseUSD | 107,183,000Source | 143,804,000Source | 157,915,000Source | 128,891,000Source |
| Nonoperating Income (Expense)USD | -3,942,000Source | -4,683,000Source | -4,837,000Source | -3,131,000Source |
| Operating Costs and ExpensesUSD | 2,734,572,000Source | — | — | — |
| Other Cost of Operating RevenueUSD | 22,567,000Source | — | — | — |
| Other Operating Income (Expense), NetUSD | — | -13,316,000Source | -6,930,000Source | 5,252,000Source |
| Research and Development ExpenseUSD | — | 13,000,000Source | 13,200,000Source | — |
Offerings
Registration 333-297475
Filing attachments
ach-ex99d1.htm · 8-K · 2026-10-09
Exhibit 99.1 Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard RICHMOND, VA - October 9, 2026 - Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with the NYSE’s continued listing standards because, the average closing price o…
Read attachment ↗ach-20260916xex99d1.htm · 8-K · 2026-09-17
EX-99.1 3 ach-20260916xex99d1.htm EX-99.1 Exhibit 99.1 Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth Gardner-Smith to Succeed Ed Pesicka Following Previously Announced Retirement Company Announces Scott Lloyd as Chief Commercial Officer Richmond, VA - September 17, 2026 - Accendra Health, Inc. (NYSE: ACH) (the “Company”) today named Kenneth Gardner-Smith as the Company’s next President and Chief Executive…
Read attachment ↗tm2622667d5_ex99-1.htm · 8-K · 2026-08-17
EX-99.1 2 tm2622667d5_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans RICHMOND, VA - August 17, 2026 - Accendra Health (the “Company”) is providing an update on its capital allocation plans and the timeline for the replacement of its chief executive officer. Given recent market conditions, the Company has determined that it is in the best interest of stakeholders not to put in place an at-the-market issuance program. The p…
Read attachment ↗tm2622667d3_ex4-1.htm · 8-K · 2026-08-10
EX-4.1 3 tm2622667d3_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 SECTION 382 RIGHTS AGREEMENT Dated as of August 10, 2026 between ACCENDRA HEALTH, INC. and Computershare TRUST COMPANY, N.A., as Rights Agent TABLE OF CONTENTS Page Section 1. Definitions 1 Section 2. Appointment of Rights Agent …
Read attachment ↗tm2622667d3_ex99-1.htm · 8-K · 2026-08-10
EX-99.1 4 tm2622667d3_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value RICHMOND, VA - August 10, 2026 - Accendra Health, Inc. (NYSE: ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the “Tax Asset Preservation Plan”) designed to protect long-term shareholder value by facilitating the Company’s ability to preserve its net operating loss carryfor…
Read attachment ↗tm2622667d2_ex99-1.htm · 8-K · 2026-08-10
EX-99.1 2 tm2622667d2_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Accendra Health Reports Second Quarter 2026 Financial Results Reduced Total Debt By $385 Million In Second Quarter CEO Ed Pesicka Announces Intention To Retire By The End of 2026 RICHMOND, VA - August 10, 2026 - Accendra Health, Inc. (NYSE: ACH) (the Company) today reported financial results for the second quarter ended June 30, 2026. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which r…
Read attachment ↗